-
1
Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax
Published 2021-01-01Subjects: Get full text
Article -
2
TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study
Published 2022-06-01Subjects: Get full text
Article